Although H3B-120 treatment initially reduced the activity of tumor-infiltrating cytotoxic CD8+ T cells, as measured by IFNγ levels, the addition of anti-PD-1 antibody restored this activity (Figure 8J and Figure S9B). Here, CD8A is linked to neoplasm.